Obinutuzumab Plus Dhap Followed by Autologous Stem Cell Transplantation (Asct) Plus Obinutuzumab Maintenance Provides a High MRD Response Rate in Untreated MCL Patients. Results of Lyma-101 Trial, a Lysa Group Study

Hematological Oncology - United Kingdom
doi 10.1002/hon.14_2629
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Obinutuzumab Plus Bendamustine in Previously Untreated Patients With CLL: A Subgroup Analysis of the GREEN Study

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

Bortezomib Plus Dexamethasone Induction Followed by Autologous Stem Cell Transplantation in Multiple Myeloma: A Study From India

Asian Journal of Medical Sciences
2016English

Obinutuzumab Plus Ibrutinib in Relapse/Refractory Mantle Cell Lymphoma Patients: First Results of the Oasis Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Phase I Dose-Escalation Study of Venetoclax Plus Beam Followed by Autologous Stem Cell Transplant (Asct) for Chemoresistant, Relapsed/Refractory, or High-Risk Non-Hodgkin's Lymphoma (Nhl); Preliminary Results

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Fixed-Duration Venetoclax Plus Obinutuzumab Improves PFS and Minimal Residual Disease Negativity in Patients With Previously Untreated CLL and Comorbidities

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Brazilian Experience Using High-Dose Sequential Therapy (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Malignant Lymphomas

Revista Brasileira de Hematologia e Hemoterapia
2009English

High Efficacy of Venetoclax Plus Obinutuzumab in Patients With Complex Karyotype (Ckt) and Chronic Lymphocytic Leukemia (Cll): A Prospective Analysis From the Cll14 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

High Dose Chemotherapy (HDT) With Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (Pts) With High Risk Solid Tumors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

The Immunologic Doublet of Lenalidomide Plus Obinutuzumab Is Highly Active in Relapsed/Refractory Follicular Lymphoma, Results of a Phase I/Ii Study

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy